Episode 287: APCCC - Early Discontinuation of Therapy in HSPC

We’re joined by Silke Gillessen and Bertrand Tombal to review the topic of the early discontinuation of therapy in patients with hormone sensitive prostate cancer, which will be further discussed at this year’s APCCC conference.
Professor Gillessen serves as the Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester, and is Head of the Department of Medical Oncology, at the Università della Svizzera Italiana in Lugano, and Director of the Oncology Institute of Southern Switzerland in Bellinzona, Switzerland.
Professor Tombal is the Chairman of the Department of Surgery and Full Professor of Urology at the Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium.